Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3105-11
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Cefazolin for injection USP and Dextrose Injection, USP (2 g, 50 mL duplex container) manufactured by B. Braun Medical Inc. due to cGMP deviations involving temperature abuse. The recall affects 39 cases distributed nationwide across the United States.
Because McKesson Medical-Surgical cannot identify the specific lot numbers received by individual customers, affected facilities were sent letters containing the distribution date and the date range when impacted product may have been shipped to them. The recall record does not specify a remedy or what action affected consumers should take.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 39 cases Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.